Trust me, you he longer you kn

5
Comment
Favorite

Im Kamal
2023-07-24

Trust me, you he longer you know market you understand that market or trading assets are dynamic and earning make suprise. Your participation rely on market data. Let the earning release, allow the market to decide. Your only work is follow. SIMPLE😎

Obey the Sell Signals: 3 Blue-Chip Stocks to Let Go

The recent rally is starting to extend to include large-cap and blue-chip stocks, but there are still some blue-chip stocks to avoid.

Obey the Sell Signals: 3 Blue-Chip Stocks to Let Go

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Report

Comment

Top
Latest

No comments yet

Most Discussed

Terms and Conditions·Privacy Policy

Company: TTMF Limited. Tech supported by Xiangshang Yixin.

Email：uservice@ttm.financial

{"i18n":{"language":"en_US"},"data":{"magic":2,"id":201207302488080,"tweetId":"201207302488080","gmtCreate":1690153641353,"gmtModify":1690153645630,"author":{"id":4107578488971860,"idStr":"4107578488971860","authorId":4107578488971860,"authorIdStr":"4107578488971860","name":"Im Kamal","avatar":"https://static.itradeup.com/news/6fbf423ef5ef66f63377e3a80cd07e5d","vip":1,"userType":1,"introduction":"","boolIsFan":false,"boolIsHead":false,"crmLevel":2,"crmLevelSwitch":1,"individualDisplayBadges":[],"fanSize":29,"starInvestorFlag":false},"themes":[],"images":[],"coverImages":[],"html":"<html><head></head><body><p>Trust me, you he longer you know market you understand that market or trading assets are dynamic and earning make suprise. Your participation rely on market data. Let the earning release, allow the market to decide. Your only work is follow. SIMPLE😎</p></body></html>","htmlText":"<html><head></head><body><p>Trust me, you he longer you know market you understand that market or trading assets are dynamic and earning make suprise. Your participation rely on market data. Let the earning release, allow the market to decide. Your only work is follow. SIMPLE😎</p></body></html>","text":"Trust me, you he longer you know market you understand that market or trading assets are dynamic and earning make suprise. Your participation rely on market data. Let the earning release, allow the market to decide. Your only work is follow. SIMPLE😎","highlighted":1,"essential":1,"paper":1,"likeSize":5,"commentSize":0,"repostSize":0,"favoriteSize":0,"link":"https://ttm.financial/post/201207302488080","repostId":2353020751,"repostType":4,"repost":{"id":"2353020751","pubTimestamp":1690079240,"share":"https://www.laohu8.com/m/news/2353020751?lang=&edition=full","pubTime":"2023-07-23 10:27","market":"us","language":"en","title":"Obey the Sell Signals: 3 Blue-Chip Stocks to Let Go","url":"https://stock-news.laohu8.com/highlight/detail?id=2353020751","media":"InvestorPlace","summary":"The recent rally is starting to extend to include large-cap and blue-chip stocks, but there are still some blue-chip stocks to avoid.","content":"<html><head></head><body><ul><li><p>The recent market rally is beginning to spread beyond the tech sector, but there are still several blue-chip stocks to avoid. </p></li><li><p><strong>Target</strong> (<strong><u>TGT</u></strong>): The company faces a $500 million hit to profit that is likely to keep stock growth muted. </p></li><li><p><strong>Netflix</strong> (<strong><u>NFLX</u></strong>): Despite what may be a solid earnings report, the SAG-AFTRA strike may weigh heavily on the company. </p></li><li><p><strong>Moderna</strong> (<strong><u>MRNA</u></strong>): Analysts forecast a higher stock price with falling earnings; the latter should inform more of your thinking.</p></li></ul><p>FOMO is carrying the day, week and month on Wall Street. And the rally is starting to spread beyond the tech sector. This means some blue-chip stocks are beginning to catch a bid. That’s encouraging news. However, while this rally may have legs, there are still some blue-chip stocks to avoid.</p><p>Blue-chip stocks are sought after for their financial stability. These companies tend to stack quarter after quarter of solid revenue and earnings. And many pay dividends, which adds to their appeal.</p><p>But no stock moves in the same direction all the time. Some investors are content to hold their stocks, knowing that a turnaround is just a matter of time. However, sometimes a better course of action is to sell and wait for another opportunity.</p><p>Remember, selling a stock doesn’t mean saying goodbye to a stock forever. It may not even mean exiting a position completely. But it does mean recognizing when the opportunity cost of holding a stock is more than the price to sell.</p><p>That’s the case with these three stocks. And that’s why they make this list of blue-chip stocks to avoid.</p><h2 id=\"id_1253588936\">Target (TGT)</h2><p>I put <strong>Target </strong>(NYSE: <strong>TGT</strong>) on a list of stocks to sell in June. Despite some periods of growth, TGT stock has been flat over the last 30 days. However, the stock may have found a floor after tumbling 18% since May.</p><p>The acute reason for the sell-off is well known. And while it was part of my consideration in May, it isn’t now. In the larger picture, the company is strong enough to overcome it. However, just because the stock may have found a bottom doesn’t mean it’s ready to rip higher.</p><p>To begin with, retail sales are softening. That offsets any benefits the company may get after rightsizing its inventory.</p><p>Second, as I wrote in May, Target expects the ongoing issue of theft and organized retail crime to negatively impact profits by $500 million year-over-year. The company’s earnings in the prior quarter were better than expected but still lower than the prior year.</p><p>Analysts are forecasting full-year profits to grow by 24%. That looks less likely, particularly if retail sales continue to soften. You can wait until the company reports June earnings to make your decision on TGT stock.</p><h2 id=\"id_1617864534\">Netflix (NFLX)</h2><p><strong>Netflix </strong>(NASDAQ: <strong>NFLX</strong>) is up 10% in the last 30 days and is getting ready to report earnings that may move the stock higher. The company’s earnings call will focus on the success of Netflix’s crackdown on password sharing and consumer adoption of its low-price Standard With Ads platform.</p><p>I have a different concern. The company relies heavily on original content to differentiate itself in an increasingly saturated and competitive market. And the current Screen Actors Guild (SAG-AFTRA) strike doesn’t help matters.</p><p>According to industry experts, streaming services will likely run out of new content by October. The strike could be over by then, but what if it’s not? Historically, Netflix has had a lower churn rate than many streaming services. And to be fair, the SAG-AFTRA strike will affect all streaming services. But it’s still a reason for concern and why it makes this list of blue-chip stocks to avoid.</p><h2 id=\"id_434644070\">Moderna (MRNA)</h2><p><strong>Moderna </strong>(NASDAQ: <strong>MRNA</strong>) makes this list of blue-chip stocks to avoid for a specific reason. The company’s pipeline, while robust, does not show any vaccines that are likely to be approved in the next 12 months.</p><p>The company is hoping that a $1 billion investment in China will boost its stock, but there’s no guarantee that it will. Specifically, Moderna is reportedly entering a memorandum of understanding and land collaboration agreement. That will allow Moderna to research, develop and manufacture vaccines that use the company’s mRNA technology in China. Initially, these vaccines would only be available in China.</p><p>Analysts suggest there could be a 39% upside to MRNA stock. And if you only look at the company’s price-to-earnings (P/E) ratio, which is around 10x, it may seem compelling. But those earnings are expected to decline sharply in the next 12 months. That makes the stock a much less certain bet.</p></body></html>","source":"investorplace_stock_picks","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Obey the Sell Signals: 3 Blue-Chip Stocks to Let Go</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nObey the Sell Signals: 3 Blue-Chip Stocks to Let Go\n</h2>\n\n<h4 class=\"meta\">\n\n\n2023-07-23 10:27 GMT+8&nbsp;&nbsp;&nbsp;<a href=https://investorplace.com/2023/07/3-blue-chip-stocks-to-avoid-as-they-give-off-sell-signals/><strong>InvestorPlace</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>The recent market rally is beginning to spread beyond the tech sector, but there are still several blue-chip stocks to avoid. Target (TGT): The company faces a $500 million hit to profit that is ...</p>\n\n<a href=\"https://investorplace.com/2023/07/3-blue-chip-stocks-to-avoid-as-they-give-off-sell-signals/\">Web Link</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"TGT":"塔吉特","MRNA":"Moderna, Inc.","NFLX":"奈飞"},"source_url":"https://investorplace.com/2023/07/3-blue-chip-stocks-to-avoid-as-they-give-off-sell-signals/","is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"2353020751","content_text":"The recent market rally is beginning to spread beyond the tech sector, but there are still several blue-chip stocks to avoid. Target (TGT): The company faces a $500 million hit to profit that is likely to keep stock growth muted. Netflix (NFLX): Despite what may be a solid earnings report, the SAG-AFTRA strike may weigh heavily on the company. Moderna (MRNA): Analysts forecast a higher stock price with falling earnings; the latter should inform more of your thinking.FOMO is carrying the day, week and month on Wall Street. And the rally is starting to spread beyond the tech sector. This means some blue-chip stocks are beginning to catch a bid. That’s encouraging news. However, while this rally may have legs, there are still some blue-chip stocks to avoid.Blue-chip stocks are sought after for their financial stability. These companies tend to stack quarter after quarter of solid revenue and earnings. And many pay dividends, which adds to their appeal.But no stock moves in the same direction all the time. Some investors are content to hold their stocks, knowing that a turnaround is just a matter of time. However, sometimes a better course of action is to sell and wait for another opportunity.Remember, selling a stock doesn’t mean saying goodbye to a stock forever. It may not even mean exiting a position completely. But it does mean recognizing when the opportunity cost of holding a stock is more than the price to sell.That’s the case with these three stocks. And that’s why they make this list of blue-chip stocks to avoid.Target (TGT)I put Target (NYSE: TGT) on a list of stocks to sell in June. Despite some periods of growth, TGT stock has been flat over the last 30 days. However, the stock may have found a floor after tumbling 18% since May.The acute reason for the sell-off is well known. And while it was part of my consideration in May, it isn’t now. In the larger picture, the company is strong enough to overcome it. However, just because the stock may have found a bottom doesn’t mean it’s ready to rip higher.To begin with, retail sales are softening. That offsets any benefits the company may get after rightsizing its inventory.Second, as I wrote in May, Target expects the ongoing issue of theft and organized retail crime to negatively impact profits by $500 million year-over-year. The company’s earnings in the prior quarter were better than expected but still lower than the prior year.Analysts are forecasting full-year profits to grow by 24%. That looks less likely, particularly if retail sales continue to soften. You can wait until the company reports June earnings to make your decision on TGT stock.Netflix (NFLX)Netflix (NASDAQ: NFLX) is up 10% in the last 30 days and is getting ready to report earnings that may move the stock higher. The company’s earnings call will focus on the success of Netflix’s crackdown on password sharing and consumer adoption of its low-price Standard With Ads platform.I have a different concern. The company relies heavily on original content to differentiate itself in an increasingly saturated and competitive market. And the current Screen Actors Guild (SAG-AFTRA) strike doesn’t help matters.According to industry experts, streaming services will likely run out of new content by October. The strike could be over by then, but what if it’s not? Historically, Netflix has had a lower churn rate than many streaming services. And to be fair, the SAG-AFTRA strike will affect all streaming services. But it’s still a reason for concern and why it makes this list of blue-chip stocks to avoid.Moderna (MRNA)Moderna (NASDAQ: MRNA) makes this list of blue-chip stocks to avoid for a specific reason. The company’s pipeline, while robust, does not show any vaccines that are likely to be approved in the next 12 months.The company is hoping that a $1 billion investment in China will boost its stock, but there’s no guarantee that it will. Specifically, Moderna is reportedly entering a memorandum of understanding and land collaboration agreement. That will allow Moderna to research, develop and manufacture vaccines that use the company’s mRNA technology in China. Initially, these vaccines would only be available in China.Analysts suggest there could be a 39% upside to MRNA stock. And if you only look at the company’s price-to-earnings (P/E) ratio, which is around 10x, it may seem compelling. But those earnings are expected to decline sharply in the next 12 months. That makes the stock a much less certain bet.","news_type":1},"isVote":1,"tweetType":1,"viewCount":593,"commentLimit":10,"likeStatus":false,"favoriteStatus":false,"reportStatus":false,"symbols":[],"verified":2,"subType":0,"readableState":1,"langContent":"EN","currentLanguage":"EN","warmUpFlag":false,"orderFlag":false,"shareable":true,"causeOfNotShareable":"","featuresForAnalytics":[],"commentAndTweetFlag":false,"andRepostAutoSelectedFlag":false,"upFlag":false,"length":209,"xxTargetLangEnum":"ORIG"},"commentList":[],"hasMoreComment":false,"orderType":2}